{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:10:51Z","timestamp":1793124651671,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:00:00Z","timestamp":1707350400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003107","name":"Bundesministerium f\u00fcr Gesundheit","doi-asserted-by":"publisher","award":["NKP-332-049"],"award-info":[{"award-number":["NKP-332-049"]}],"id":[{"id":"10.13039\/501100003107","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ejca.2024.113915","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T03:27:59Z","timestamp":1707449279000},"page":"113915","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["An audit of 1632 routinely collected cervical cancer screening smears from 398 women in Germany: Results from the TeQaZ Study"],"prefix":"10.1016","volume":"201","author":[{"given":"Luana F.","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6922-7148","authenticated-orcid":false,"given":"Olaf","family":"Schoffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Schriefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0392-1580","authenticated-orcid":false,"given":"Gunther","family":"Schauberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Ikenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie J.","family":"Klug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2024.113915_bib1","unstructured":"Zentrum f\u00fcr Krebsregisterdaten, Gesellschaft de Epidemiologischen Krebsregister in Deutschland E.V. Krebs in Deutschland f\u00fcr 2017\/2018. Berlin 2021."},{"key":"10.1016\/j.ejca.2024.113915_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253801","article-title":"Impact of opportunistic screening on squamous cell and adenocarcinoma of the cervix in Germany: a population-based case-control study","volume":"16","author":"Tanaka","year":"2021","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ejca.2024.113915_bib3","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1002\/ijc.22114","article-title":"Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands","volume":"119","author":"Bos","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2024.113915_bib4","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00292-015-0120-1","article-title":"Zervixkarzinome in Mecklenburg-Vorpommern - Tumorstadium, histologischer Tumortyp, Alter und Screeningteilnahme von 985 Patientinnen","volume":"37","author":"Marquardt","year":"2016","journal-title":"Pathologe"},{"key":"10.1016\/j.ejca.2024.113915_bib5","unstructured":"Gemeinsamer Bundesausschuss. Richtlinie des Gemeinsamen Bundesausschusses f\u00fcr organisierte Krebsfr\u00fcherkennungsprogramme. 2023. Available from: \u3008https:\/\/www.g-ba.de\/richtlinien\/104\/\u3009."},{"key":"10.1016\/j.ejca.2024.113915_bib6","unstructured":"Institut f\u00fcr Qualit\u00e4tssicherung und Transparenz im Gesundheitswesen. Zervixkarzinomscreening Konzept einer gestuften Evaluation. Stand: 30. November 2017. Berlin 2017. Available from \u3008https:\/\/iqtig.org\/downloads\/berichte\/2018\/IQTIG_Evaluationskonzept-Zervixkarzinomscreening_Abschlussbericht_2018\u201304-09.pdf\u3009."},{"key":"10.1016\/j.ejca.2024.113915_bib7","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1007\/s00103-018-2835-7","article-title":"Cervical cancer screening in Germany","volume":"61","author":"Bujan Rivera","year":"2018","journal-title":"Bundesgesundheitsblatt Gesundh Gesundh"},{"key":"10.1016\/j.ejca.2024.113915_bib8","first-page":"392","article-title":"M\u00fcnchner Nomenklatur II f\u00fcr die gyn\u00e4kologische Zytodiagnostik - Munich II nomenclature for gynaecological cytodiagnosis of the cervix","volume":"39","author":"Hilgarth","year":"2001","journal-title":"Frauenarzt"},{"key":"10.1016\/j.ejca.2024.113915_bib9","first-page":"1","article-title":"M\u00fcnchner Nomenklatur III","volume":"54","author":"Griesser","year":"2013","journal-title":"Frauenarzt"},{"key":"10.1016\/j.ejca.2024.113915_bib10","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/aje\/kwu159","article-title":"An updated natural history model of cervical cancer: derivation of model parameters","volume":"180","author":"Campos","year":"2014","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ejca.2024.113915_bib11","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/0895-4356(91)90149-4","article-title":"Sensitivity and specificity of a diagnostic test determined by repeated observations in the absence of an external standard","volume":"44","author":"Schulzer","year":"1991","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ejca.2024.113915_bib12","series-title":"Chapter 4: Histological groups. Cancer Incidence in Five Continents, Volume XI","author":"Ferlay","year":"2017"},{"key":"10.1016\/j.ejca.2024.113915_bib13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2303.2007.00451.x","article-title":"European guidelines for quality assurance in cervical cancer screening: recommendations for cytology laboratories","volume":"18","author":"Wiener","year":"2007","journal-title":"Cytopathology"},{"key":"10.1016\/j.ejca.2024.113915_bib14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2303.2007.00464.x","article-title":"European guidelines for quality assurance in cervical cancer screening: recommendations for collecting samples for conventional and liquid-based cytology","volume":"18","author":"Arbyn","year":"2007","journal-title":"Cytopathology"},{"key":"10.1016\/j.ejca.2024.113915_bib15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12907-017-0058-8","article-title":"Accuracy of cervical cytology: comparison of diagnoses of 100 Pap smears read by four pathologists at three hospitals in Norway","volume":"17","author":"S\u00f8rbye","year":"2017","journal-title":"BMC Clin Pathol"},{"key":"10.1016\/j.ejca.2024.113915_bib16","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1158\/1055-9965.EPI-09-1038","article-title":"Low proportion of false-negative smears in the Finnish program for cervical cancer screening","volume":"19","author":"L\u00f6nnberg","year":"2010","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.ejca.2024.113915_bib17","doi-asserted-by":"crossref","first-page":"613","DOI":"10.5858\/arpa.2013-0083-CP","volume":"138","author":"Crothers","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ejca.2024.113915_bib18","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00292-007-0931-9","article-title":"Reevaluation von Zervixabstrichen bei Zervixkarzinompatientinnen: regionales Qualit\u00e4tssicherungsprogramm unter Mitwirkung der \u00d6sterreichischen Gesellschaft f\u00fcr Zytologie, der K\u00e4rntner \u00c4rztekammer und der Landessanit\u00e4tsdirektion K\u00e4rntens","volume":"28","author":"Regitnig","year":"2007","journal-title":"Der Pathol"},{"key":"10.1016\/j.ejca.2024.113915_bib19","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/oxfordjournals.aje.a117485","article-title":"Meta-analysis of pap test accuracy","volume":"141","author":"Fahey","year":"1995","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ejca.2024.113915_bib20","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7326\/0003-4819-132-10-200005160-00009","article-title":"Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review","volume":"132","author":"Nanda","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejca.2024.113915_bib21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ijgo.2015.07.024","article-title":"Systematic reviews and meta-analyses of the accuracy of HPV tests, visual inspection with acetic acid, cytology, and colposcopy","volume":"132","author":"Mustafa","year":"2016","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ejca.2024.113915_bib22","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1080\/0284186X.2020.1764095","article-title":"Increase of cervical cancer incidence in Sweden in relation to screening history: population cohort study","volume":"59","author":"Wang","year":"2020","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejca.2024.113915_bib23","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1159\/000515912","article-title":"Nationwide rereview of normal cervical cytologies before high-grade cervical lesions or before invasive cervical cancer","volume":"65","author":"Edvardsson","year":"2021","journal-title":"Acta Cytol"},{"key":"10.1016\/j.ejca.2024.113915_bib24","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/ijc.33320","article-title":"Methylation markers FAM19A4 and miR124-2 as triage strategy for primary human papillomavirus screen positive women: a large European multicenter study","volume":"148","author":"Bonde","year":"2021","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2024.113915_bib25","unstructured":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft DK, AWMF). S3-Leitlinie Pr\u00e4vention des Zervixkarzinoms, Langversion 1.1, 2020. In: AWMF, editor. Leitlinienprogramm Onkologie 2020. Available from: \u3008http:\/\/www.leitlinienprogramm-onkologie.de\/leitlinien\/zervixkarzinom-praevention\/\u3009."},{"key":"10.1016\/j.ejca.2024.113915_bib26","unstructured":"Gemeinsamer Bundesausschuss. Beschlussbegr\u00fcndung - \u00c4nderung der Richtlinien \u00fcber die Fr\u00fcherkennung von Krebserkrankungen (\"Krebsfr\u00fcherkennungs-Richtlinien\"). 2005. Available from: \u3008https:\/\/www.g-ba.de\/downloads\/40\u2013268-48\/2005\u201307-19-Abstrich_Begruendung.pdf\u3009."},{"key":"10.1016\/j.ejca.2024.113915_bib27","first-page":"484","article-title":"Zervixzytologie: Der repr\u00e4sentative Abstrich","volume":"52","author":"Marquardt","year":"2011","journal-title":"Frauenarzt"},{"key":"10.1016\/j.ejca.2024.113915_bib28","article-title":"Guideline adherence in cervical cancer screening in Germany. 17 Jahrestagung der Deutschen Gesellschaft f\u00fcr Epidemiologie (DGEpi)","author":"Nischwitz","year":"2022","journal-title":"Greifswald"},{"key":"10.1016\/j.ejca.2024.113915_bib29","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/jnci\/djaa066","article-title":"Accuracy and efficiency of deep-learning\u2013based automation of dual stain cytology in cervical cancer screening","volume":"113","author":"Wentzensen","year":"2021","journal-title":"JNCI"},{"key":"10.1016\/j.ejca.2024.113915_bib30","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/ijc.30152","article-title":"Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix?","volume":"139","author":"Castanon","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2024.113915_bib31","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1158\/1055-9965.EPI-07-0278","article-title":"A longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: evidence of effectiveness and overtreatment","volume":"16","author":"Gunnell","year":"2007","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.ejca.2024.113915_bib32","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/ijc.22357","article-title":"Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies","volume":"120","author":"International Collaboration of Epidemiological Studies of Cervical Cancer","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2024.113915_bib33","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1158\/1055-9965.EPI-20-1003","article-title":"Cervical cancer screening: comparison of conventional Pap smear test, liquid-based cytology and human papillomavirus testing as stand-alone or co-testing strategies","volume":"30","author":"Liang","year":"2021","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.ejca.2024.113915_bib34","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2303.2006.00310.x","article-title":"Review of cervical smears from 76 women with invasive cervical cancer: cytological findings and medicolegal implications","volume":"17","author":"Coleman","year":"2006","journal-title":"Cytopathology"},{"key":"10.1016\/j.ejca.2024.113915_bib35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2303.2010.00816.x","article-title":"Review of negative and low-grade cervical smears in women with invasive cervical cancer after the first 3 years of the national cervical screening programme in Slovenia","volume":"23","author":"Rep\u0161e-Fokter","year":"2012","journal-title":"Cytopathology"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804924000911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804924000911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T18:23:29Z","timestamp":1778783009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804924000911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":35,"alternative-id":["S0959804924000911"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2024.113915","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An audit of 1632 routinely collected cervical cancer screening smears from 398 women in Germany: Results from the TeQaZ Study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2024.113915","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"113915"}}